The Use of Essential Phospholipids for the Treatment of Fatty Liver Disease
Journal Title: Гастроентерологія - Year 2016, Vol 4, Issue 62
Abstract
Background. Given the similarity of histopathological pattern of non-alcoholic fatty liver disease and alcoholic liver disease, it was proposed to combine these both diseases in one nosological form named «fatty liver disease». The purpose of this review was to evaluate the efficacy and safety of essential phospholipids for the treatment of fatty liver disease. Methodology. When performing this review, re-analysis of 25 studies included in the review K.J. Gundermann et al. (2016), has been made. In these studies, essential phospholipids were obtained from soybeans containing not less than 72 % phosphatidylcholine. Results. It was found that essential phospholipids reduce the severity of symptoms, including general malaise, fatigue, nausea, incidence of hepatic pain, abdominal distension, constipation, obesity index and skin-fold thickness when used in nonalcoholic fatty liver disease (20 studies). Essential phospholipids were found to improve biochemical blood plasma markers (liver function tests — alanine aminotransferase, serum glutamic oxalacetic transaminase, gamma-glutamyl transpeptidase, alkaline phosphatase, markers of lipid metabolism — total cholesterol, triglycerides, LDL cholesterol). Essential phospholipids improved the results of sonography and computed tomography of the liver in 60–75 % of patients. At the same time there observed the reverse of histopathological changes in the liver: decreased severity of steatosis, ballooning, intra-acinar and portal inflammation, leading to a decrease of the stage of steatohepatitis by Brunt classification. The total efficiency of the treatment with essential phospholipids was 80.5 %, while the total efficiency of the treatment in the placebo or «no treatment» groups was 27.9 % (p < 0.05). Similar results were obtained for the alcoholic liver disease (5 studies), but more researches are needed. Data from all the above cited studies suggest that the treatment of essential phospholipids was safe. Conclusion. In 25 clinical studies it was confirmed the effectiveness and safety of the essential phospholipids for the treatment of fatty liver disease.
Authors and Affiliations
Yu. M. Stepanov
Keywords
Related Articles
- EP ID EP210253
- DOI 10.22141/2308-2097.4.62.2016.81089
- Views 107
- Downloads 0
Changes in prostaglandin levels in the blood serum of patients with gastroesophageal reflux disease on the background of type 2 diabetes mellitus
Background. Digestive organ damage in patients with diabetes mellitus (DM) is based on several mechanisms: autonomic nervous system dysfunction, angiopathy, dysregulation of secretion and inactivation of hormones and inc...
Diseases of the hepatobiliary system: focus on rational hepatotropic therapy
The article presents data of the modern literature and our studies on the combined use of ursodeoxycholic acid and arginine glutamate in the pathology of the hepatobiliary system. Hepatobiliary diseases today remain a ma...
Evaluating the risk factors for liver injury in patients with chronic lymphocytic leukemia in the dynamics of chemotherapy
Background. B-cell chronic lymphocytic leukemia (B-CLL) treatment is accompanied by a risk of liver injury due to factors that depend on the characteristics of the patient, tumor, and chemotherapy (CT). The purpose was t...
Antibacterial Therapy of Acute Cholecystitis and Cholangitis (According to Tokyo Guidelines2013)
Gallstone disease and inflammatory diseases of the biliary tract is a serious problem in health protection in developed countries. Acute cholecystitis is the third major cause of the urgent hospitalization to the surgica...
Features of Bacterial Overgrowth Syndrome and Gut Flora Imbalance in Patients with Portal Hypertension
Objective: to evaluate the clinical features of patients with portal hypertension (PH) and the bacterial overgrowth syndrome (BOS). Methods. We observed 67 patients with PH syndrome aged from 43 to 81 years old, who have...